A Landscape of Artificial Intelligence (AI) In Pharmaceutical R&D

Where you find opportunities to grow

* Can't find your brand, product, service? Join BPT Marketplace

Healthcare

Section: Biopharma Insights     View all sections


[Interview] Shaping European AI Regulation To Secure Global Leadership In Healthcare

   by Andrii Buvailo    681
[Interview] Shaping European AI Regulation To Secure Global Leadership In Healthcare

While the history of Artificial Intelligence (AI) field began in the distant 1950s, its practical value had largely remained limited all the way until the emergence of powerful hardware (GPUs) in the late 1990s. Other complementary technologies played an important role in the AI progress too: new data storage capabilities, cheap cloud infrastructures, advanced deep learning algorithms -- all these things became reality only in the 21st century, effectively setting AI field for exponential development trajectory and commercial practical utility. 

Today AI tech has matured to an extent it has become a strategic factor, a competitive differentiator, not only for individual companies but for the whole industries and countries. Needless to say, healthcare -- one of the major industries -- is an important end-user of AI technologies. Countries that care to adopt AI in their healthcare strategies today will have major competitive benefits for public health and safety tomorrow.